167 related articles for article (PubMed ID: 27225050)
1. Disposition and metabolism of TAK-438 (vonoprazan fumarate), a novel potassium-competitive acid blocker, in rats and dogs.
Kogame A; Takeuchi T; Nonaka M; Yamasaki H; Kawaguchi N; Bernards A; Tagawa Y; Morohashi A; Kondo T; Moriwaki T; Asahi S
Xenobiotica; 2017 Mar; 47(3):255-266. PubMed ID: 27225050
[TBL] [Abstract][Full Text] [Related]
2. Study on pharmacokinetics and bioequivalence of Vonoprazan pyroglutamate in rats by liquid chromatography with tandem mass spectrometry.
Qiao Y; Zhao J; Yue X; Zhang Y; Zhang R; Xu Y; Tang X; Liu X; Wang Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1059():56-65. PubMed ID: 28578848
[TBL] [Abstract][Full Text] [Related]
3. A validated simultaneous quantification method for vonoprazan (TAK-438F) and its 4 metabolites in human plasma by the liquid chromatography-tandem mass spectrometry.
Yoneyama T; Teshima K; Jinno F; Kondo T; Asahi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():42-49. PubMed ID: 26896571
[TBL] [Abstract][Full Text] [Related]
4. Radiographic Localization Study of a Novel Potassium-Competitive Acid Blocker, Vonoprazan, in the Rat Gastric Mucosa.
Matsukawa J; Kogame A; Tagawa Y; Inatomi N
Dig Dis Sci; 2016 Jul; 61(7):1888-94. PubMed ID: 26961787
[TBL] [Abstract][Full Text] [Related]
5. Disposition and metabolism of the G protein-coupled receptor 40 agonist TAK-875 (fasiglifam) in rats, dogs, and humans.
Kogame A; Lee R; Pan L; Sudo M; Nonaka M; Moriya Y; Higuchi T; Tagawa Y
Xenobiotica; 2019 Apr; 49(4):433-445. PubMed ID: 29557709
[TBL] [Abstract][Full Text] [Related]
6. The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations.
Echizen H
Clin Pharmacokinet; 2016 Apr; 55(4):409-18. PubMed ID: 26369775
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of TAK-475, a Squalene Synthase Inhibitor, in Rats and Dogs.
Ebihara T; Teshima K; Kondo T; Tagawa Y; Moriwaki T; Asahi S
Drug Res (Stuttg); 2016 Jun; 66(6):287-92. PubMed ID: 26839207
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and disposition of [14C]BMS-690514 after oral administration to rats, rabbits, and dogs.
Hong H; Su H; Sun H; Allentoff A; Ekhato IV; Chando T; Caceres-Cortes J; Roongta V; Iyer RA; Humphreys WG; Christopher LJ
Drug Metab Dispos; 2010 Jul; 38(7):1189-201. PubMed ID: 20363952
[TBL] [Abstract][Full Text] [Related]
9. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
10. In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker.
Yamasaki H; Kawaguchi N; Nonaka M; Takahashi J; Morohashi A; Hirabayashi H; Moriwaki T; Asahi S
Xenobiotica; 2017 Dec; 47(12):1027-1034. PubMed ID: 27414183
[TBL] [Abstract][Full Text] [Related]
11. Disposition of the new potent acetylcholinesterase inhibitor 8-[3-[1-[(3-fluorophenyl)methyl]-4-piperidiny]-1-oxopropyl]-1, 2, 5, 6-tetrahydro-4H-pyrrolo [3, 2, 1-ij] quinolin-4-one (TAK-802) in rats, dogs and monkeys.
Kakehi M; Tagawa Y; Kondo T; Asahi S
Drug Res (Stuttg); 2013 Jun; 63(6):293-9. PubMed ID: 23585302
[TBL] [Abstract][Full Text] [Related]
12. Physiologically based pharmacokinetic-pharmacodynamic modeling for prediction of vonoprazan pharmacokinetics and its inhibition on gastric acid secretion following intravenous/oral administration to rats, dogs and humans.
Kong WM; Sun BB; Wang ZJ; Zheng XK; Zhao KJ; Chen Y; Zhang JX; Liu PH; Zhu L; Xu RJ; Li P; Liu L; Liu XD
Acta Pharmacol Sin; 2020 Jun; 41(6):852-865. PubMed ID: 31969689
[TBL] [Abstract][Full Text] [Related]
13. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
14. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and excretion of atorvastatin in rats and dogs.
Black AE; Hayes RN; Roth BD; Woo P; Woolf TF
Drug Metab Dispos; 1999 Aug; 27(8):916-23. PubMed ID: 10421619
[TBL] [Abstract][Full Text] [Related]
16. Disposition of TAK-044, a new endothelin antagonist, in rats and dogs.
Maeshiba Y; Takeuchi T; Kondo T; Yamashita K; Tsukuda R; Yoshimura Y
Arzneimittelforschung; 2002; 52(8):587-92. PubMed ID: 12236045
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
Denissen JF; Grabowski BA; Johnson MK; Buko AM; Kempf DJ; Thomas SB; Surber BW
Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549
[TBL] [Abstract][Full Text] [Related]
19. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.
Paulson SK; Zhang JY; Breau AP; Hribar JD; Liu NW; Jessen SM; Lawal YM; Cogburn JN; Gresk CJ; Markos CS; Maziasz TJ; Schoenhard GL; Burton EG
Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
